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Zika virus caused of the emerging infections characterized by fever, Guillain-
Barré syndrome (GBS) for adults. In the current work, we aimed to study the 
binding orientation of 1,5-benzothiazepine compounds as new potential 
agent against Zika virus inhibitor through molecular docking and molecular 
dynamic simulation. Since, 1-5-Benzothiazepines are particular interest for 
drug discovery and they also has some biological activities. However, their 
antiviral activities and in silico studies of the binding to their biological targets 
have not been extensively investigated. Molecular docking study of 1,5-
benzothiazepine chalcone derivatives compounds with protein target 5GJB 
(PDB ID) and this protein was taken from the crystallographic structure. In 
this study, twelve 1,5-benzothiazepine chalcone derivative compounds were 
docked to the protein with the grid box along x, y and z radius of 26.85, 28.17 
and 24.43 Å, respectively. Suramin was used as positive control. Thus, it can 
be used as a reference for design new inhibitors for Zika virus helicase. Based 
on the docking results, it is observed that compounds MA3 and MA8 are 
estimated to have activity as inhibitors for Zika virus helicase with binding 
free energy values of -4.6490 and -4.9291 kcal/mol, respectively. MA3 and 
MA8 were also stable during the MD simulations with the hydrogen bonding 
are still maintained before and after MD simulation. Furthermore, both of 
these compounds can be used an early stage for drug design and drug 
delivery process.  
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Introduction 
Zika virus (ZIKV) is a type of Arbovirus from the 
genus Flavivirus. This virus has a relationship 
with other Arboviruses like Dengue, Yellow 
Fever, Japanese Encephalitis, and West Nile 
Virus. This virus was first isolated in 1947 from 
saliva of a monkey in a study of Yellow Fever[1]. 
There are some reports reported about the 
infections of  Zika virus, one of them reported 
that in vitro studies on fibroblasts exposed to 
Zika virus shown high rates of infection from 24 
to 48 hours after the onset of infection[2]. Some 
symptoms were shown such as rash, fever, 
conjunctivitis, myalgia, arthralgia, weakness, 
and headaches[1]. 
Tan et. al reported that suramin was used as 
potential ZIKV infection in Vero cells. 
Unfortunately, De-sulfated heparin analogues 
lose the inhibitory effect, this may cause that 
sulfonate group are critical for viral inhibition. 
In addition, the inhibitory effect of 
glycosaminoglycans and analogues against 
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ZIKV infection[3].  Thus, there are no reports 
about vaccine for this virus and there is also no 
approved vaccine that can be used to attack this 
Zika virus until now. Since there are no vaccine 
to attack this ZIKV, patient has been treated 
using their immune responses[4].  
1,5-benzothiazepine chalcone has been 
synthesized by previous researcher[5] derivative 
compounds consisted of seven-loop heterocyclic 
compound containing nitrogen and sulfur[6]. 1,5-
benzothiazepine chalcone derivative compound 
is a compound that has some biological activities 
such as antimicrobial[7]–[9], an anticonvulsant 
agent[10], Plasmodium falciparum cytochrome bc1 
inhibitors[11], anti-HIV[12] and pulmonary 
anticancer[13]. However, the antiviral activities 
like Zika virus inhibitor have not been 
extensively investigated. 
The number of structural as well as non-
structural protein from ZIKV that have 
enzymatic function. The drug design and drug 
discovery was used the enzymatic resolution at 
high resolution as the main target. NS3 helicase 
is one of the enzymatic function, its was able 
inhibition in ZIKV makes the virus unable to 
replicate and duplicate[14]. Furthermore, in this 
research we used NS3 helicase  with PDB ID 
5GJB as the main target for ZIKV. 
Rationally, the main goal is to explore the 
potency of 1,5-benzothiazepine chalcone 
derivative compounds to bind with the active 
site of the Zika virus helicase receptor. In silico 
study such as molecular docking and molecular 
dynamic simulation (MD) are able to identify the 
promising compounds with high activity and 
also less toxicity according to the binding free 
energy value[15]. To date, chalcone derivative 
heterocycles like 1,5-benzothiazepine chalcone 
derivative compounds have not extensively 
studied for the Zika virus inhibitors. In addition, 
there are not many reports about discovering 
new inhibitors for Zika virus using 
computational like molecular docking and MD 
simulation. The aim of this study is to determine 
the potentiality of the 1,5-benzothiazepine 
chalcone derivative compounds as new 
inhibitors for Zika virus helicase using 
molecular docking and MD simulation with 
suramin as a positive control. 
Experimental 
Materials 
The computational research was performed 
using computer LG Intel(R) Core (TM) i7-8700 
CPU, 3.20 GHz, with 16,0 GB of RAM, 
ChemDraw Professional 15.0, Molecular 
Operating Environment (MOE 2019.0101, CCG), 
Windows 10. Twelve of 1,5-benzothiazepine 
chalcone derivative compounds[5], protein target 
5GJB[16] from modeling helicase enzyme 




The molecular structure of twelve 1,5-
benzothiazepine has been synthesized[5] and 
suramin were sketched using ChemDraw 
Professional software thus, saved with .cdx 
format and then converted into pdb format 
using discovery studio visualizer (DSV, Biovia) 
software package. The molecular structures of 
twelve 1,5-benzothiazepine chalcone derivative 
compounds and suramin are depicted in Table 
1. 
Protein preparation 
Three-dimensional structures of 5GJB were 
obtained from the protein databank 
(www.rscb.org) in the .pdb. format with 
resolution of 1.7Å. Then, the initial ligand and 
water molecules should be removed. Next is 
adding hydrogen atoms and energy 
minimization. The last stage is fixed the energy 
minimization for backbone atoms and also alpha 
carbons. Protein was prepared using MOE 
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Tabel 1. Molecular structure of the ligand 
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Molecular docking was performed using MOE 
2019.01 (Chemical computing group). It was 
begun with set up some docking parameters, 
CHARMM27 (Chemistry HARvard 
Macromolecular Mechanics) was selected as 
force field. The dimension along x, y and z 
radius were set up to be 26.85, 28.17 and 24.43 Å, 
respectively. The lowest binding free energy was 
selected as the best docking conformation from 
all the emerged results. 
Molecular dynamic simulation 
MD simulation was performed for 1,5-
benzothiazepine chalcone derivative 
compounds-protein complexes using NAMD 
(Nanoscale Molecular Dynamics program v 2.9) 
software package. In this case, CHARMM27 was 
selected as the best force field. Modeled protein 
was achieved for each direction of coordinated 
structure using TIP3P water box with the 
distances of 2.5 Å. 
The system was heated using NVT ensemble 
from 0 to 300 K over 100 ps. Time scale was set 
up for 50 ns for each system in an isothermal 
isobaric ensemble (NPT) in periodic boundary 
conditions. Temperature and pressure were set 
as a coupling for 1.0 ps. Conformation of each 
coordinates were then saved every 0.1 ps during 
the sampling process. From this simulation, 
some conformations were generated for then the 
best conformation was selected for further 
binding free energy calculation. 
Results and Discussion 
Docking plays an important role in the rational 
drug design which are often used to predict the 
appropriate orientation and binding site of small 
molecule to their target protein to ascertain their 
affinity and activity[17]. Molecular docking has 
the advantage of filtering large compound 
databases at a relatively lower cost compared 
than experimental methods, it is also time-
saving, cost-effective, and more productive. In 
the previous study, it was reported that 
molecular docking was able to identify 
promising compounds that could be solutions in 
the health sector in the future, namely by 
predicting a ligand-receptor binding site 
model[15]. In this study, molecular docking is 
begun with the selection of protein as a target 
and ligands. These ligands were attached to the 
protein. The ligand structure of 1,5-
benzothiazepine and positive control (suramin) 
from ChemDraw was copied and pasted into the 
MOE program for then create a new database. 
Meanwhile, 3D protein crystallography 
extraction is available on the website 
www.rcsb.org/pdb in PDB format. 5GJB protein 
crystallography is carried out by deleting the 
native ligand on the protein structure. The main 
goal is to explore the potency of 1,5-
benzothiazepine chalcone derivative 
compounds to bind with the active site of the 
Zika virus helicase receptor. The water 
molecules in the protein must be removed, this 
is to avoid the bonding between these water 
molecules with the protein and it can interfere 
the data analysis[18]. The protein provided in 
protein databank, it needs to add the hydrogen 
atom to ensure that each atom in the molecule 
has a charge during receptor preparation[19] 
because in general the interactions that occur 
between ligands and receptors are in the form of 
hydrogen bonds. Energy minimization is also 
important when preparing protein against alpha 
carbon, backbone atoms, and sidechain atoms to 
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stabilize the bonds protein-ligand. The docking 
process is carried out for 10 times for each ligand 
in order to obtain the best binding free energy 
value[20]. The docking results are presented in 
Table 2.  
There are some parameters used to analyze the 
docking results such as Root Mean Square 
Deviation (RMSD), the docking method is valid 
if it has a RMSD less than 2 Å[18]. The RMSD 
value describes the deviation value from errors 
that occur when docking. Smaller of the RMSD 
value indicated that the error deviation in the 
docking is also small. The binding free energy is 
useful for describing how the test ligand can 
binds well with the receptor. The lower value of 
the binding free energy is indicated that the 
binding between ligand and receptor is more 
stable[21]. Hydrogen bonding is also become 
parameter to select the best conformation of 
docking results. Generally, hydrogen bond can 
be defining as one of the most non-covalent 
bonds found in the biological systems[22]. This 
bonding occurs between positively charged 
hydrogen atoms and atoms that have high 
electronegativity such as O, N, and F[23]. 
 







Factor of Binding 
with Suramin 




MA1 -4.7422 0.6881 Lys607, His603 Lys610 Glu579, Glu611 Lys610, Lys607, 
Lys616 
MA2 -4.3766 2.0469 Arg388, Ala264 Arg388 - Arg388, Arg226 
MA3 -4.6490 1.3074 Asp574, Glu573 Arg367, Glu573 Asp574, Asp602, 
Glu573 
Arg367 
MA4 -4.7583 2.5208 Arg388, Asp291, 
Ala264 
- Asp291 Arg226, Arg388 
MA5 -4.5734 1.3242 His603, Glu573, 
Asp574 
Ser601 Asp574, Glu573 Arg367 
MA6 -4.2467 1.0413 Asp574 Asp574 Asp574 Arg367 
MA7 -4.5490 1.9705 His603, Glu573, 
Asp574 
- Asp574, Glu573 Arg367 
MA8 -4.9291 1.4669 Glu573, His603, 
Asp574 
Arg367 Glu573, Asp574, 
Asp602 
Arg367 
MA9 -4.7536 0.9691 - Lys537 - Lys537, Arg538, 
Arg269 
MA10 -4.4337 0.7039 Arg388, Lys389 Arg388 - Arg388, Lys389 
MA11 -4.9251 1.4280 - Pro277 Glu256, Asp259 Arg275, Arg242, 
Arg218, Arg269 
MA12 -4.5822 3.4292 - - - Arg538, Lys537, 
Arg269 
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In addition, hydrogen bonds can also be formed 
between the H atom with the phenyl ring 
contained in a medicinal compound[24]. There is 
also another binding such as van der Waals 
interaction and hydrophobic bonds which are 
supporting bonds to determine whether a 
compound has good activity or not. 
Compounds MA3 and MA8 have the lowest 
binding free energy values. The smaller 
(negative) of the binding free energy value, it is 
indicated that, the smaller energy required for 
the ligand-protein interactions. So that the 
binding between ligand and protein become 
more stable and increased their predicted 
activity[25]. Two hydrogen bonds are formed in 
MA3 compound. Much more hydrogen bonds 
formed are predicted to increase the ligand 
activity as an inhibitor of the Zika virus helicase. 
In addition, these two compounds also have 
factor of binding (i.e., measure of probability 
that a tested compound will bind to the same 
amino acid residues to which the control 
compound, suramin binds) calculated by 
docking may predict which compounds will be 
more active Zika helicase inhibitors. 
Compounds MA3 and MA8 were predicted to 
be active as inhibitors for Zika virus helicase, it 
was observed in their spatial arrangement using 
DSV as depicted in Figure 1. Superimposition 
describes the shape and the best poses of the 
ligand. It was seen from the compounds that 
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From the superimposed results, it is found that 
MA3 and MA8 compounds have the same 
conformations and orientations with the native 
ligands in the 5GJB protein (i.e., Based on Figure 
2), MA3 and MA8 compounds shown specificity 
with the hydrophobic amino acid residues and 
also hydrogen bonds through Arg367, Glu573 
through van der Waals bonds. Thus, MA3 and 
MA8 compounds can inhibit the Zika virus 
helicase with the same mechanism as the native 
ligand. 
MA3 and MA8 were exhibited crucial binding 
affinities (i.e. hydrogen bond) with residue 
Arg367 at the protein active site which seems to 
be significant for activity prediction. Hence, 
MA3 and MA8 considered potentially active as 
ZIKV and can be further utilized in drug 
designing process. 
MD simulation was applied to MA3 and MA8 to 
ensure that the interaction between ligand and 
protein are still maintained[26].  Visualization of 
the MD simulation are presented in Figure 3. 
The efficiency of hydrogen bonding for both of 
these compounds i.e., MA3 and MA8 were 
checked before and after MD simulation for 50 
ns and 300K. 
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Based on the MD results, the conformation of   
MA3 and MA8 were maintained to bind well 
with same residues before and after MD 
simulation process. In addition, the existence of 
the hydrogen bond distance is less than 2.9 Å. It 
is indicated that both of these compounds can be 
used as potential inhibitor for Zika virus 
helicase. 
Conclusions 
MA3 and MA8 compounds have met all the 
expected docking parameters, besides that they 
also have a greater number of amino acid 
matches against positive control and also the 
lowest value of binding free energy compared 
than other compounds. These two compounds 
were also able to maintain the hydrogen 
bonding with the distances less than 2.9 Å.  
Furthermore, these two compounds can be used 
as an early stage for drug design and drug 
discovery against Zika virus helicase. 
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